Overview
Status
Active
Registry date
2021-12-28
Share capital
1,644,000.00 PLN
Registered address
ul. Geodetów 31, 05-500 Piaseczno, Poland
Electronic delivery address
AE:PL-81060-38492-RWCHB-27
Financials
Revenue history (in k)
Filing timeliness
1 of 5 financial statements was filed late (for 2021, 5 days late).
- 202507/04/2026
- 202411/07/2025
- 202317/05/2024
- 202217/03/2023
- 202120/07/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.48mMedianUSD 178.92kAverageUSD 6.85m
Net profit
This companyUSD 42.07kMedianUSD 2.73kAverageUSD 466.49k
Operating costs
This companyUSD 2.37mMedianUSD 175.18kAverageUSD 6.10m
Assets
This companyUSD 1.28mMedianUSD 160.35kAverageUSD 5.64m
Industry
Trademarks
Michel Laboratory holds 3 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2007.
| Mark | Protected until | |
|---|---|---|
| 4 PURE MANICURE | Mar 21, 2029 | |
| OWOCOWY POCAŁUNEK(word) | Apr 27, 2027 | |
| Mark without a word element(figurative) | Apr 27, 2027 | |
| BIO HELPY | – | |
| Bioteq BIOLOGY & TECHNOLOGY | – |
Authorized Representatives
Elżbieta Pawluczuk – President of the Management Board
Manner of representation
The President of the Management Board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Antoni Krasuski | 164 | $44,300.38 | 9.9757% |
Elżbieta Pawluczukage 59 | 1,480 | $399,783.90 | 90.0243% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1997-12-29.
30 1020 1068 0000 1402 0522 3369
78 1090 1694 0000 0001 6373 7571
39 1240 6351 1111 0000 4813 3847
Debt
No entries in the National Debtors Register (KRZ).
Public aid
14 public aid cases recorded, with a total value of $76,201.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| May 14, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 14, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Colorissp. z o.o. | $3,886,330.94 | coloris.sklep.pl | ||
| Prino-Plastsp. z o.o. | $3,250,767.43 | prino-plast.pl | ||
| Miracansp. z o.o. | $3,146,011.90 | miracan.pl | ||
| VGS Polskasp. z o.o. | $3,014,237.85 | bolonia.vgspolska.com | ||
| Procosmetica sp. z o.o.sp. k. | $2,426,902.10 | procosmetica.com.pl | ||
| KANU Naturesp. z o.o. | $2,341,781.01 | kanunature.eu | ||
| Clocheesp. z o.o. | $2,124,392.73 | clochee.com | ||
| Laboratorium Ambroziaksp. z o.o. | $1,854,134.54 | drambroziak.com | ||
| Organic LifeS.A. | $1,544,477.74 | organiclife.com.pl | ||
| Red Pharma Laboratories PolskaS.A. | $1,369,528.53 | red-pharma.com |
FAQ
The main business activity of Michel Laboratory focuses on manufacture of perfumes and toilet preparations.
The company was registered in the Polish National Court Register (KRS) on December 28, 2021.
The headquarters is located at: ul. Geodetów 31, 05-500 Piaseczno.
The share capital of the company is PLN 1,644,000 (approx. $444,084).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 2,477,726 in 2025, which is a decrease of 35.8% compared to 2024.
Yes, in 2025 the company achieved a net profit of USD 42,067.
The largest operating cost category falls under materials and energy. This category amounted to USD 1,110,610 in 2025, representing 47% of all operating expenses.
Last updated: 2026-10-21